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Abstract
Background: Primary malignant tracheal tumors are rare, accounting for approximately 0.2 % of respiratory tract
tumors yearly, with squamous cell carcinomas and adenoid cystic carcinomas accounting for two-thirds of these
cases. Sarcomatoid carcinomas are a group of poorly differentiated non-small cell lung carcinomas containing a
component of sarcoma or sarcoma-like (spindle and/or giant cell) differentiation, categorized into five morphologic
subgroups. Spindle cell sarcomatoid carcinoma is a rare variant of sarcomatoid carcinomas, consisting of only
spindle-shaped tumor cells. Only one other case has been reported as a primary tracheal tumor.
Case presentation: We present a 75-year-old male, having progressive dyspnea and cough, with a spindle cell
sarcomatoid carcinoma tumor visualized on chest computed tomography scan and confirmed with biopsy.
Conclusions: Due to its low incidence, knowledge of treatment methods, prognostic factors, and etiology is
limited thus approaches to eradication have widely varied. We are reporting the second published case of spindle cell
sarcomatoid carcinoma of the trachea and the first reported successful outcome of definitive treatment with tracheal
resection.
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Background
Primary tracheal tumors are rare, with malignancy oc-
curring at a rate of 0.1 new cases per 100,000 every year,
corresponding to 0.2 % of all tumors involving the re-
spiratory tract [1]. Primary tracheal cancers are more
common in current or former male cigarette smokers,
with peak incidence in the sixth decade of life [2, 3].
Due to the central location and tendency to protrude
into the lumen of the large airways, patients typically
present with symptoms of dry cough, hemoptysis, pro-
gressive dyspnea, hoarseness, and fevers secondary to re-
current pneumonia, often leading to misdiagnosis of
asthma or chronic pulmonary disease [4, 5]. Squamous
cell carcinoma (SCC) and adenoid cystic carcinoma
(ACC) make up nearly two thirds of primary tracheal
cases. Tracheal tumors apart from these are extremely
uncommon and consist of a heterogeneous group of
benign and malignant tumors, with only one other re-
ported case of primary tracheal spindle cell carcinomas
to date [6, 7].
Spindle cell carcinoma belongs to a group of poorly
differentiated non-small cell carcinomas known as sarco-
matoid carcinomas. According to the World Health
Organization 2004 classifications of lung tumors, this
group contains components of sarcoma or sarcoma-like
(spindle cell or giant cell) differentiation, consisting of
only spindle shaped cells that form cohesive nests and
irregular fascicles of malignant cells with features includ-
ing nuclear hyperchromasia and distinct nucleoli [4].
These tumor masses include scattered and focally dense
regions of lymphoplasmacytic infiltrates throughout [4].
Due to the rarity of these tracheal cases, there is often
a delay in diagnosis and inappropriate treatment ap-
proaches [2]. Additionally, no universally accepted TNM
classification for tracheal malignancies exists, and pro-
posed staging systems are based on a small number of
considered cases [1, 8]. Generally, tracheal carcinomas
have poor prognosis, with 5-year survival rates of up to
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15 % and 10-year survival rates of 7 % [1]. On the other
hand, the spindle cell group of carcinomas are described
to be aggressive and thought to have worse clinical out-
comes than conventional non-small cell carcinomas.
Five-year survival rates are only 20 % despite many
patients presenting with stage I disease [4]. Adjuvant
chemotherapy and radiation do not seem to play a help-
ful role in treatment of spindle cell type tumors, and
thus resection remains the mainstay of tumor eradica-
tion [4]. Here we report a case of a former smoker pre-
senting with progressive dyspnea, discovered to have
primary tracheal spindle cell sarcomatoid carcinoma
treated definitively with surgical resection.
Case presentation
A 75 year-old Caucasian male presented with progres-
sively worsening dyspnea of eight days, wheezing and
productive cough with clear sputum. His symptoms
began abruptly, worsened upon exertion, and were unre-
lieved by home albuterol inhaler. The patient is a former
smoker with a 52 pack-year history, quitting four years
prior to the onset of his symptoms. His past medical his-
tory is significant for chronic obstructive pulmonary dis-
ease (COPD) and atherosclerotic disease involving his
peripheral and carotid arteries. His past surgical history is
unremarkable, and lungs were clear to auscultation with
stridor on physical exam at the time of his presentation.
A chest computed tomography (CT) scan was per-
formed with contrast demonstrating a 1.5 cm x ×
1.3 cm × 1.3 cm nodular soft tissue lesion within the
subglottic trachea, causing 50 % reduction in cross-
sectional area of the tracheal lumen (Fig. 1). The patient
subsequently underwent bronchoscopy. A biopsy of the
tracheal mass was simultaneously obtained, with a pre-
operative diagnosis of T1aN0M0 primary spindle cell
sarcomatoid-type carcinoma [9]. The patient’s lesion in-
volved trachea of resectable length, without ingrowth to
irresectable structures such as the larynx, and without
lymph node involvement. Thus, the initial workup and
isolated nature of disease deemed the patient a good sur-
gical candidate [10–13].
We performed a standard tracheal resection of the
tumor located 8 cm from the carina, arising from the
posterior membranous trachea, with primary anasto-
mosis (Figs. 2 and 3). Three tracheal rings were resected,
including one ring on each side of the mass. The sample
was sent off for frozen pathological review, which con-
firmed negative margins for invasive cancer. An end-to-
end reconstruction was then performed. The incision
was closed in layers and a Grillo stitch was placed in the
patient’s chin to prevent hyperextension in the postoper-
ative period. The patient was extubated immediately
postoperatively and taken to the surgical intensive care
unit for recovery.
Final pathology of the polypoid, firm, tan-white lesion
measured 1.8 cm × 1.5 cm × 0.8 cm, invading 2.5 mm
into the membranous posterior tracheal wall without in-
volvement of the tracheal cartilage (Fig. 4). Microscopic
evaluation was consistent with spindle cell sarcomatoid
carcinoma given its biphasic characteristic (Fig. 5). The
primary component was a high-grade neoplasm showing
enlarged pleomorphic nuclei with spindle cell features.
Markedly atypical squamous epithelial cells with en-
larged nuclei, prominent nucleoli, and increased mitoses
were adjacent to the spindled areas. Along with this
thorough pathological review special stains were per-
formed to the specimen to confirm diagnosis in the form
of Pankeratin and OSCAR cytokeratin immunostains,
which were positive for the atypical squamous cells. No
additional molecular testing was performed. Margins
were measured at 0.5 cm both proximal and distally with
clear posterior radial margin of at least 3 mm All mar-
gins were negative for malignancy, and no evidence of
lymphovascular or perineural invasion was found. Final
Fig. 1 a (left): Chest computed tomography scan sagittal view demonstrating a 1.5 cm nodular soft tissue lesion within the upper subglottic
thoracic trachea, 8 cm from carina. b (right): Axial view of the lesion resulting in greater than fifty-percent reduction in cross-sectional area of the
tracheal lumen
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pathology correlated with preoperative TNM status as
T1aN0M0 as per current classification for tracheal ma-
lignancies [8].
Following the procedure, the patient reported im-
provement in breathing and stridor. After an eight-day
hospital course, he self-ambulated on room air, tolerated
oral intake, and denied pain or difficulty swallowing or
breathing. At his six month post-operative follow-up, he
continued to do well without complications or evidence
of recurrence. The patient is under observation by both
surgery and oncology, with regularly scheduled CT scans
to monitor for recurrence.
Discussion
Surgical management is well established as the definitive
treatment for primary tracheal tumors [9, 10, 14]. Re-
sectability of these tumors depends most on locoregional
disease characteristics over distant characteristics and is
associated with survival superior to palliative therapy, es-
pecially when complete resection with negative margins
is achieved [12]. The role for adjuvant therapy with
chemotherapy or radiation is variable and most recom-
mendations are based on retrospective analysis for non-
specific squamous cell histology-associated outcomes
[15] and/or for cases where there is advanced disease,
other than R0 resection, unresectable tumors or when
the patient is not a surgical candidate. Among patients
with tracheal tumors, survival in those undergoing
complete resections is significantly longer than those
undergoing alternative modalities of treatment, although
the rarity of these tumors and complexity in selecting
treatment options has allowed for limited analysis of
outcomes [5, 16].
In the first reported case of primary tracheal spindle
cell carcinoma, cisplatin-based chemotherapy with radi-
ation was the treatment chosen by patient preference,
however, the regimen was not completed due to patient
death within five months of diagnosis [7]. In our case, a
complete tracheal sleeve resection was performed, with
anastomosis of the regions above and below the resected
region (Figs. 2 and 3). Resection alone has thus far
proved to be effective in management of this rare case,
Fig. 2 Intraoperative sterile endotracheal tube placed in the
trachea following tracheal resection and removal of initial
endotracheal tube
Fig. 3 Stay sutures placed in the distal and proximal ends to
reapproximate the trachea following tracheal resection
Fig. 4 Gross pathology of the sarcomatoid tumor shows a polypoid,
firm, tan-white lesion measuring 1.8 cm × 1.5 cm × 0.8 cm, invading
2.5 mm into posterior tracheal wall
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as the patient has been without complications through-
out his postoperative period. Further follow up will be
needed to assess the long-term success of this treatment
option.
Conclusion
Spindle cell carcinoma or sarcomatoid carcinoma of the
trachea is an uncommon tumor. Because the lesion
caused greater than a fifty-percent reduction in trachea
luminal diameter, this patient experienced obstructive
symptoms such as dyspnea and cough resulting in early
detection prior to metastasis. The isolated nature of dis-
ease allowed for successful tracheal resection.
As various tracheal tumors have been characterized
across reviews, corresponding treatment approaches
have widely varied with little evidence pointing towards
a single best modality for management [5]. The opera-
tive technique described here may serve as a principal
reference for future tracheal spindle cell sarcomatoid
carcinomas with similar properties. Additionally as more
cases are reported, this case contributes to a better un-
derstanding of tumor growth predilection along the
trachea, tumor size, and possible distant metastasis,
allowing for improved assessment of appropriate surgical
candidates and higher long-term survival with reduced
operative morbidity and mortality.
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